Building Blocks
This section contains fundamental products for the synthesis of organic and biological compounds. Building blocks are the essential starting materials used to construct complex molecules through various chemical reactions. They play a critical role in drug discovery, material science, and chemical research. At CymitQuimica, we offer a diverse range of high-quality building blocks to support your innovative research and industrial projects, ensuring you have the essential components for successful synthesis.
Subcategories of "Building Blocks"
- Boronic Acids & Boronic Acid Derivatives(5,778 products)
- Chiral Building Blocks(1,242 products)
- Hydrocarbon Building Blocks(6,098 products)
- Organic Building Blocks(61,098 products)
Found 199594 products of "Building Blocks"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Methyl 1-(cyclopropylamino)cyclobutane-1-carboxylate
CAS:<p>Versatile small molecule scaffold</p>Formula:C9H15NO2Purity:Min. 95%Molecular weight:169.22 g/molRef: 3D-YZB27235
Discontinued product4-[Bromo(phenyl)methyl]-1,2-difluorobenzene
CAS:<p>Versatile small molecule scaffold</p>Formula:C13H9BrF2Purity:Min. 95%Molecular weight:283.11 g/molRef: 3D-YZB27890
Discontinued product2-[(1-Phenyl-1H-pyrazol-4-yl)(2-phenylhydrazin-1-ylidene)methyl]phenol
CAS:<p>Versatile small molecule scaffold</p>Formula:C22H18N4OPurity:Min. 95%Molecular weight:354.4 g/molRef: 3D-ZCA99094
Discontinued product3-Bromo-6-fluoro-2-hydroxybenzaldehyde
CAS:<p>Versatile small molecule scaffold</p>Formula:C7H4BrFO2Purity:Min. 95%Molecular weight:219.01 g/mol5-Methyl-2-(piperazin-1-yl)-1,3-benzoxazole
CAS:<p>Versatile small molecule scaffold</p>Formula:C12H15N3OPurity:Min. 95%Molecular weight:217.27 g/molRef: 3D-ZHA29273
Discontinued product3-Amino-5-cyano-benzoic acid methyl ester
CAS:<p>Versatile small molecule scaffold</p>Formula:C9H8N2O2Purity:Min. 95%Molecular weight:176.17 g/mol4-(1-Methyl-1H-pyrazol-4-yl)benzoic acid
CAS:<p>Versatile small molecule scaffold</p>Formula:C11H10N2O2Purity:Min. 95%Molecular weight:202.21 g/molRef: 3D-ZHA67806
Discontinued productrac-tert-Butyl (3R,4R)-3-amino-4-benzylpyrrolidine-1-carboxylate
CAS:<p>Versatile small molecule scaffold</p>Formula:C16H24N2O2Purity:Min. 95%Molecular weight:276.4 g/molRef: 3D-ZLD00142
Discontinued product3-{[(tert-Butoxy)carbonyl]amino}hex-5-ynoic acid
CAS:<p>Versatile small molecule scaffold</p>Formula:C11H17NO4Purity:Min. 95%Molecular weight:227.26 g/molRef: 3D-ZXC23909
Discontinued product8-[(tert-Butoxy)carbonyl]-2-oxa-8-azaspiro[4.5]decane-6-carboxylic acid
CAS:<p>Versatile small molecule scaffold</p>Formula:C14H23NO5Purity:Min. 95%Molecular weight:285.3 g/molRef: 3D-ZLD00165
Discontinued producttert-Butyl N-{8-azabicyclo[3.2.1]octan-3-yl}-N-methylcarbamate hydrochloride
CAS:<p>Versatile small molecule scaffold</p>Formula:C13H25ClN2O2Purity:Min. 95%Molecular weight:276.8 g/molRef: 3D-ZLD00175
Discontinued product[1-(Aminomethyl)-2-oxabicyclo[2.2.2]octan-4-yl]methanol hydrochloride
CAS:<p>Versatile small molecule scaffold</p>Formula:C9H18ClNO2Purity:Min. 95%Molecular weight:207.7 g/molRef: 3D-ZLD00801
Discontinued product2-Amino-4-(ethanesulfonyl)benzoic acid
CAS:<p>Versatile small molecule scaffold</p>Formula:C9H11NO4SPurity:Min. 95%Molecular weight:229.26 g/molRef: 3D-ZMB03320
Discontinued productLithium 2-{[(tert-butoxy)carbonyl]amino}-2-cyanoacetate
CAS:<p>Versatile small molecule scaffold</p>Formula:C8H11LiN2O4Purity:Min. 95%Molecular weight:206.1 g/mol(2-Cyano-4-fluorophenyl)methanesulfonyl chloride
CAS:<p>Versatile small molecule scaffold</p>Formula:C8H5ClFNO2SPurity:Min. 95%Molecular weight:233.65 g/molRef: 3D-IAC65229
Discontinued product1-Benzothiophene-6-carboxylic acid
CAS:<p>1-Benzothiophene-6-carboxylic acid is a nicotinic acetylcholine receptor agonist that has been shown to have high oral bioavailability and efficacy in vivo. It binds to the α7 nicotinic acetylcholine receptor and activates the receptor, leading to increased neurotransmitter release. 1-Benzothiophene-6-carboxylic acid has been shown to be effective in vivo in models of neuropathic pain and Parkinson's disease. This drug also has a low affinity for other receptors, such as muscarinic acetylcholine receptors, which reduces the chance of adverse effects.</p>Formula:C9H6O2SPurity:Min. 95%Molecular weight:178.21 g/mol2,5-Dimethoxypyridine-4-boronic acid
CAS:<p>Versatile small molecule scaffold</p>Formula:C7H10BNO4Purity:Min. 95%Molecular weight:182.97 g/molMethyl 2-hydroxy-2-(pyridin-3-yl)acetate hydrochloride
CAS:<p>Versatile small molecule scaffold</p>Formula:C8H10ClNO3Purity:Min. 95%Molecular weight:203.62 g/molRef: 3D-IAC65252
Discontinued productMethyl 4-methyl-3-{[(2,2,2-trifluoroethoxy)carbonyl]amino}benzoate
CAS:<p>Versatile small molecule scaffold</p>Formula:C12H12F3NO4Purity:Min. 95%Molecular weight:291.22 g/molRef: 3D-IDC91849
Discontinued product3-Iodobenzene-1,2-diamine
CAS:<p>Versatile small molecule scaffold</p>Formula:C6H7IN2Purity:Min. 95%Molecular weight:234.04 g/molRef: 3D-JBA44643
Discontinued product4-Chloro-2-methyl-5-nitroaniline
CAS:<p>4-Chloro-2-methyl-5-nitroaniline is an organic compound with the chemical formula C6H4ClNO2. It is a nitro derivative of aniline. 4-Chloro-2-methyl-5-nitroaniline is a white solid that is soluble in water, alcohols, and ethers. It has a melting point around 206 °C and decomposes at temperatures over 350 °C. This compound can be obtained by reacting hydroxylamine with nitrous acid and chlorinating 2,5-dimethylaniline. The sequence of reactions can be summarized as follows: hydroxy group to nitro group, nitro group to methyl group, methyl group to acetyl or acetylamino, acetyl or acetylamino to acetylation or methylation, transformation from hydroxyl group to amino group and esterification from acid hydrazide to acid group.</p>Formula:C7H7ClN2O2Purity:Min. 95%Molecular weight:186.59 g/mol7-Bromo-3,4-dihydro-2H-1-benzothiopyran 1,1-dioxide
CAS:<p>Versatile small molecule scaffold</p>Formula:C9H9BrO2SPurity:Min. 95%Molecular weight:261.14 g/molRef: 3D-FJB99737
Discontinued product4,6,7-Trichloroquinoline
CAS:<p>4,6,7-Trichloroquinoline is an anticancer drug that was first synthesized in the late 1950s. It is a type of 1,2-dihydroquinoline that has been modified by the addition of three chlorine groups. 4,6,7-Trichloroquinoline inhibits the growth of cancer cells by inducing DNA strand breaks and inhibiting DNA synthesis and protein synthesis. This drug also induces cell death through the release of reactive oxygen species. 4,6,7-Trichloroquinoline binds to tumor cells and inhibits their proliferation by binding to DNA molecules and preventing them from replicating. The hydrolysis process for this compound occurs in two steps: first it is hydrolyzed into diethylmalonate and ethoxymethylenemalonate; then it undergoes cyclization with condensation and decarboxylation to form a quinolinium salt.</p>Formula:C9H4Cl3NPurity:Min. 95%Molecular weight:232.5 g/mol2-(4-Methoxyphenyl)-1-(4-methylphenyl)-6-oxopiperidine-3-carboxylic acid
CAS:<p>Versatile small molecule scaffold</p>Formula:C20H21NO4Purity:Min. 95%Molecular weight:339.4 g/mol1-Amino-7,7-dimethylbicyclo[2.2.1]heptan-2-one hydrochloride
CAS:<p>Versatile small molecule scaffold</p>Formula:C9H16ClNOPurity:Min. 95%Molecular weight:189.7 g/molRef: 3D-JBA78312
Discontinued product1-(Chloromethoxy)-4-fluorobenzene
CAS:<p>Versatile small molecule scaffold</p>Formula:C7H6ClFOPurity:Min. 95%Molecular weight:160.57 g/molRef: 3D-JBA88802
Discontinued productQuinoline-5-carbonitrile
CAS:<p>Quinoline-5-carbonitrile is a cyanide compound that can be used in the synthesis of heterocyclic compounds. The reaction between quinoline and 5-cyanovaleric acid produces 6-nitroquinoline, which is then converted to dimethyl sulfoxide by alcoholysis. This reaction product can then be used to synthesize an amide or nucleophile. Quinoline-5-carbonitrile reacts with potassium in the presence of bifunctional hydrazide to produce a cyanide ion, which can be hydrolyzed by an acid to release hydrogen cyanide gas. This experiment has been shown as a model for reactions involving cyano compounds.</p>Formula:C10H6N2Purity:Min. 95%Molecular weight:154.17 g/molRef: 3D-JCA55102
Discontinued product6-(Methylsulfanyl)-2,3-dihydro-1H-indole-2,3-dione
CAS:<p>Versatile small molecule scaffold</p>Formula:C9H7NO2SPurity:Min. 95%Molecular weight:193.22 g/molRef: 3D-JCA86843
Discontinued product1-(3-Amino-4-methylphenyl)-3,3-dimethylurea
CAS:<p>Versatile small molecule scaffold</p>Formula:C10H15N3OPurity:Min. 95%Molecular weight:193.25 g/molRef: 3D-JKC05686
Discontinued product3-({[6-(Ethoxycarbonyl)-5-methyl-4-oxo-3H,4H-thieno[2,3-d]pyrimidin-2-yl]methyl}sulfanyl)propanoic acid
CAS:<p>Versatile small molecule scaffold</p>Formula:C14H16N2O5S2Purity:Min. 95%Molecular weight:356.4 g/molRef: 3D-GGB62660
Discontinued product3-(4-Fluorophenyl)-2-oxopropanoic acid
CAS:<p>Versatile small molecule scaffold</p>Formula:C9H7FO3Purity:Min. 95%Molecular weight:182.15 g/mol2-(Pent-4-en-1-yl)-2,3-dihydro-1H-isoindole-1,3-dione
CAS:<p>Versatile small molecule scaffold</p>Formula:C13H13NO2Purity:Min. 95%Molecular weight:215.25 g/mol4-Bromophenyl chloroformate
CAS:<p>Versatile small molecule scaffold</p>Formula:C7H4BrClO2Purity:Min. 95%Molecular weight:235.46 g/mol1,3-Dichloro-5,6-dihydro-4H-cyclopenta[c]thiophen-4-one
CAS:<p>Versatile small molecule scaffold</p>Formula:C7H4Cl2OSPurity:Min. 95%Molecular weight:207.08 g/mol1-Bromo-2-(2-bromoethanesulfonyl)ethane
CAS:<p>Versatile small molecule scaffold</p>Formula:C4H8Br2O2SPurity:Min. 95%Molecular weight:279.98 g/molRef: 3D-HAA61767
Discontinued product1-(Prop-2-yn-1-yl)-1,4-diazepane dihydrochloride
CAS:<p>Versatile small molecule scaffold</p>Formula:C8H16Cl2N2Purity:Min. 95%Molecular weight:211.13 g/molRef: 3D-IAC65107
Discontinued product2-Acetylbenzoic acid
CAS:<p>2-Acetylbenzoic acid is a functional molecule that contains an acetyl group. It can form hydrogen bonds with other molecules and has been shown to induce apoptosis in cells. The reaction products of 2-acetylbenzoic acid are malonic acid, acetylsalicylic acid, and 2-benzoylbenzoic acid. These three compounds are made by the addition of hydrogen or hydroxide to the molecule 2-acetylbenzoic acid. The molecule has two functional groups: a carbonyl group and an acetyl group. The chemical structure of this molecule can be seen in the figure below.<br>2-Acetylbenzoic Acid</p>Formula:C9H8O3Purity:Min. 95%Color and Shape:PowderMolecular weight:164.16 g/molRef: 3D-FA05086
Discontinued product2-Bromo-3,3,3-trifluoro-1-propene
CAS:Controlled Product<p>2-Bromo-3,3,3-trifluoro-1-propene is a chemical compound that has been synthesized in an asymmetric reaction. The reactant is bromopropane and the product is 2,2,2-trifluoropropene. The methylene group on the propene molecule is activated by the nucleophilic attack of a fluoride ion from hydrogen fluoride to form a cavity with a highly strained bond. The kinetic study of this reaction revealed that the activation energy for the reaction is 42 kJ/mol. Palladium-catalyzed coupling reactions are catalyzed by palladium and require nonpolar solvents such as toluene or dichloromethane. This type of reaction has been shown to be exothermic with an isolated yield of 1%.</p>Formula:C3H2BrF3Purity:Min. 95%Color and Shape:Colorless PowderMolecular weight:174.95 g/mol3-Methylbenzo[b]thiophene-2-carboxylic acid
CAS:<p>3-Methylbenzo[b]thiophene-2-carboxylic acid (MBTCA) is a heterocyclic compound that is an intermediate in the synthesis of 3-methylthiophene-2-carboxylic acid, a precursor to other drugs. MBTCA is an aerobic, nonpolar compound that has shown antimicrobial activity against some bacteria and fungi. It also has been shown to have practicality as a biomolecular probe for methyl groups in organic solvents. MBTCA can be synthesized by nitration of benzene in the presence of sulfur and sulfoxides. This reaction produces nitrobenzene, which can then be oxidized by potassium permanganate or hydrogen peroxide to produce MBTCA. The most common isomer of MBTCA is 2-(3,5-dimethoxybenzylidene)tetrahydrofuran, with three methyl groups on the</p>Formula:C10H8O2SPurity:Min. 95%Molecular weight:192.23 g/mol3-Boc-3-azabicyclo[3.2.1]octan-8-amine
CAS:<p>Versatile small molecule scaffold</p>Formula:C12H22N2O2Purity:Min. 95%Molecular weight:226.32 g/mol3-amino-6-bromopyridin-2-ol hydrobromide
CAS:<p>Versatile small molecule scaffold</p>Formula:C5H6Br2N2OPurity:Min. 95%Molecular weight:269.9 g/mol3-(Methoxycarbonyl)pyridine-4-carboxylic acid
CAS:<p>Versatile small molecule scaffold</p>Formula:C8H7NO4Purity:Min. 95%Molecular weight:181.15 g/mol2-Bromo-4-(4-fluorophenyl)-1,3-thiazole
CAS:<p>Versatile small molecule scaffold</p>Formula:C9H5NFSBrPurity:Min. 95%Molecular weight:258.11 g/molGivinostat hydrochloride
CAS:<p>Givinostat hydrochloride is a research chemical that has shown potential in various fields. It is a molybdenum-based compound that has been studied for its effects on dopamine release and hydrogen evolution. Givinostat hydrochloride has also been investigated as an osteoclast inhibitor, which may be beneficial in the treatment of bone-related disorders such as osteoporosis. Additionally, it has shown promise as a retinoid and calpain inhibitor, suggesting its potential use in dermatological conditions and neurodegenerative diseases. The compound contains fluorine atoms, making it suitable for imaging studies using fluorine MRI techniques. Givinostat hydrochloride has been tested on MDA-MB-231 cells and has shown inhibitory effects on their growth, indicating its potential as an anticancer agent.</p>Formula:C24H27N3O4·HClPurity:Min. 95%Molecular weight:457.95 g/mol
